Posts Tagged ‘Allen Frances’

Australia’s Outrageous Mental Health Agenda Under Attack from Leading U.S. Psychiatrist

Thursday, June 16th, 2011

The 'Pre Psychosis Risk' Scam

While the United States unfortunately leads the world in labeling its children with mental ‘disorders’ which cannot be scientifically proven to exist as medical conditions,  Australia seems determined to take over  the [dishonorable] title.  And they just might do it.   For poised to carry them into the winners circle is none other than psychiatrist and former “Australian of the Year”  Patrick McGorry.   The scam is called “pre-psychosis risk syndrome” which simply translates as this:  Despite the fact there is not one proven scientific or medical test to prove any child has a mental “disorder,”  Patrick McGorry maintains he can determine who will develop one.  That’s right.   He can determine who will develop a mental disorder before they develop a mental disorder that cannot be medically proven to exist.   If that sounds a little crazy to you,  rest assured, you’re not alone.    In fact,  the logic is so backwards that McGorry’s plan has come under fire from U.S. psychiatrist Allen Frances, who chaired the committee that produced the psychiatric diagnostic bible of “mental disorders” used the world over, ‘The Diagnostic and Statistical Manual of Mental Disorders (DSM) IV.    If you’re in the mental health “business,” like McGorry is,  then that is called being attacked from altitude.

Frances calls McGorry a “false prophet” and says “Australia, led astray by his impractical hopes, is about to embark on a vast and untried public health experiment that will almost surely cause more harm to its children than it prevents.”

We agree.  And it looks like Australians are starting to catch on….

from The Australian—June 16th, 2011

Schism opens over ills of the mind

PATRICK McGorry is the face of mental health in Australia. He put the subject on the public agenda through his GetUp! ads at last year’s federal election and was instrumental in securing $2.2 billion in government funding for his cause in last month’s budget.

But now he and his early psychosis prevention and intervention centres are under attack from members of his own psychiatric profession.

At stake is the credibility of the centres that treat people aged 15-24. A $222 million program to establish 16 EPPICs is an important plank in Julia Gillard’s mental health reforms. Tony Abbott also wants to expand the centres as part of his mental health policy.

McGorry is no stranger to controversy. In 2006 Time magazine in an article headlined “Drugs before diagnosis?” was critical of his work testing the use of anti-psychosis drugs on pre-psychosis patients in the late 1990s.

West Australian Labor MP Martin Whitely has been conducting a campaign against McGorry on his blog Speed Up and Sit Still.

Many of McGorry’s mental health colleagues have questioned whether his centres got the bulk of extra money in the budget’s mental health reforms because the government wanted to silence its biggest critic. There are other models and other priorities for mental health funding, they say.

This week McGorry came under fire from US psychiatrist Allen Frances, the man who chaired the committee that produced the psychiatric diagnostic bible Diagnostic and Statistical Manual of Mental Disorders IV.

Underlying the attack on McGorry is a dispute dividing psychiatry worldwide: is there a danger that attempts to define mental illnesses are making a disease out of everyday suffering resulting in the unnecessary medication of patients?

Frances says he was very conservative when he produced DSM IV, including only two out of 84 suggested new mental illness diagnoses. After its publication, diagnoses of autism, attention deficit hyperactivity disorder and bipolar disorder skyrocketed.

“Once the genie was out of the bottle and heavy drug marketing followed and the internet and ADHD and school services [began] being tied to a diagnosis, the manual gets used differently to the way you thought it should and you have no control over it,” he says.

Frances says anti-psychotic drugs are now the leading revenue producing drugs in the US.

“It’s an astounding fact that 5 per cent of all scripts in the US are written for anti-psychotics. The industry in America is $US15bn and it is the No 1 seller of all drugs and anti-depressants are the fourth biggest sellers,” he says.

“What we’re talking about is a massive worldwide experiment in the use of anti-psychotics.”

Frances fears a similar outbreak of over-diagnosis of mental illness and unnecessary medication of patients could follow the new DSM 5, due out in 2013.

The root of Frances’s dispute with McGorry is the Melbourne psychiatrist’s work in trying to develop a tool that can diagnose patients before they develop full-blown psychosis and finding ways to treat them to prevent the illness.

This tool has various names: psychosis risk syndrome, attenuated psychotic syndrome or ultra high-risk syndrome.

This new diagnosis is a candidate for inclusion in DSM 5. But it is a highly controversial issue in the psychiatric profession and its listing is opposed by one of McGorry’s research partners, Melbourne University psychiatrist Alison Yung.

Yung and Frances fear listing the disorder will lead to teenagers being labelled and stigmatised and given powerful anti-psychotic drugs that have side effects including substantial weight gain.

Read the rest of the article here:

http://www.theaustralian.com.au/news/features/schism-opens-over-ills-of-the-mind/story-e6frg6z6-1226075910650

« Return to news items


Share

US expert slams Patrick McGorry’s psychosis model

Monday, June 13th, 2011

Note from CCHR:   CCHR International was the first organization  to expose  the complete insanity of psychiatrist and “Australian of the Year” Patrick McGorry’s campaign to “pre-diagnose” children before they ‘develop” mental disorders.  But we’re no longer the only ones.   Even his fellow psychiatrists are attacking it.  Let’s just break it down; psychiatrists admit there are no medical tests in existence to prove any child suffers from a mental ‘illness.”  Diagnoses is based solely on opinion, yet more than 20 million children worldwide have been ‘diagnosed’ and prescribed dangerous and potentially lethal drugs based on nothing more than psychiatry’s junk science.     Yet this doesn’t seem to be a problem to McGorry, or Australia for that matter, considering they just allocated $400 million to McGorry’s  crystal ball theory of “pre-diagnoses,”  for ‘psychosis’ adding even  more lunacy to the child labeling and drugging epidemic that is literally killing kids.   Now that, is psychotic – and it’s psychiatrist Patrick McGorry that’s leading the way.

The Australian – June 14, 2011

by Sue Dunlevy

PATRICK McGorry’s model of early diagnosis of psychosis, favoured by the federal government and the Coalition in their mental-health policies, has come under attack from a leading US psychiatrist, who warns that predicting psychosis is unreliable and could lead to patients being wrongly medicated.

Allen Frances, who chaired the committee that produced the current diagnostic bible for psychiatry, the DSM-IV, has warned that Professor McGorry’s Early Psychosis Intervention Centres do not have a reliable early diagnosis tool.

Professor Frances, an emeritus professor at Duke University in North Carolina, fears early diagnosis could lead to people without psychosis being put on medications that have serious side-effects, including massive weight gain.

He has also attacked the Gillard government’s plans to spend $222 million expanding Professor McGorry’s EPIC program by another 16 centres as a “vast untried public-health experiment”.

“The Australian experiment will be flying blind on an airplane that is not at all ready to leave the ground,” he said in a blog posted on Psychology Today in the US.

His concerns are shared by Adelaide University psychiatry professor Jon Juredini, who says the Gillard government should have shared mental-health funding around many different early intervention projects to see what worked best. “A lot of the evaluation of EPIC shows any advantages it has disappear over time, so that tends to suggest that in terms of intervention they are good while they are happening, but they don’t necessarily give long-term protection,” Professor Juredini told The Australian.

Their criticism came as the past president of the Royal Australian College of Psychiatrists, Louise Newman, attacked the $197 million the government will spend on expanding the number of Headspace youth mental health centres from 60 to 90.

“There have been certain statements about the efficacy of  the Headspace approach that have been overstated,” she told Australian Doctor magazine.

Early intervention to prevent mental illness needed to happen at a much earlier stage of development than adolescence, Dr Newman said.

A spokeswoman for Mental Health Minister Mark Butler said the government was making substantial investments in youth mental health and early psychosis prevention services. “We are confident these evidence-based models will be of benefit to young Australians,” she said.

Professor Frances’s arguments have been seized on by Scientologists, who argue against the notion of mental illness.

Although Professor Frances chaired the committee that produced the fourth version of the Diagnostic and Statistical Manual of Mental Disorders in 1994, he has been left off the panel developing the fifth version.

He has written extensively of his concerns about how strict medical definitions of mental illness can lead to misdiagnosis by non-experts.

Professor McGorry dismissed Professor Frances’s attack as a “beat-up”, and said no one received anti-psychotic drugs at his centres unless they had had a psychotic episode.

While Professor Frances agreed that Professor McGorry did not recommend anti-psychotic medication as a preventive measure, he feared general practitioners might overuse the drugs if they started using Professor McGorry’s diagnostic tool for early psychosis.

Professor Frances said in his Psychology Today blog that early intervention to prevent psychosis required first that there be an accurate tool to identify who would become psychotic.

“The false positive rate in selecting pre-psychosis is at least 60-70 per cent in the very best hands and may be as high as 90 per cent in general practice . . . these are totally unacceptable odds,” he said.

Professor McGorry agreed that false positive rates of diagnosing prepsychosis were high, but said the first line of treatment for people who had sub-threshold psychosis was supportive care.

http://www.theaustralian.com.au/national-affairs/us-expert-slams-patrick-mcgorrys-psychosis-model/story-fn59niix-1226074544901

« Return to news items


Share

Australia’s Reckless Experiment In Early Intervention

Wednesday, June 8th, 2011

Note from CCHR: The article below was written by Allen Frances, a psychiatrist, and former Chairman of the DSM IV task force.  The subject of the article is Australian psychiatrist Patrick McGorry and his agenda to pre- diagnose kids with mental ‘illness’ before they develop it, which  Frances calls  a dangerous and risky proposition.    It is.  Yet Frances seems to be making excuses for the fact that McGorry’s plan is not only dangerous – its criminal.    He calls McGorry a charismatic psychiatrist, which may be true, but this is exactly what makes him so dangerous.  Because the Australian government has just funded a program so controversial and dangerous to children that even other psychiatrists, leaders in the field, are speaking out against it.  And why did they fund it?   Because “charistmatic” Patrick McGorry sold them  a $400 million bill of goods.

“Charisma is a tricky thing.  Jack Kennedy oozed it–but so did Hitler and Charles Manson. Con artists, charlatans, and megalomaniacs can make it their instrument as effectively as the best CEOs, entertainers, and presidents.” Patricia Sellers, FORTUNE Magazine


prevention that will do more harm than good

Psychology Today
By Allen Frances
May 31, 2011

Patrick McGorry is a charismatic psychiatrist who has recently gained heroic status. First he was chosen to be Australia’s Man Of The Year. Now, he has convinced the Australian government to spend more than $400 million over five years to fund his plan for a nationwide system of Early Psychosis Prevention and Intervention Centres. McGorry is the visionary prophet and pied piper of preventive psychiatry. His goal is to diagnose mental disorders early and treat them expectantly- before they can do their worst damage.

McGorry’s goal is certainly great. But its current achievement is simply impossible and Australia’s plans are patently premature. Early intervention to prevent psychosis requires first that there be an accurate tool to identify who will later become psychotic and who will not. Unfortunately, no such accurate tool exists. The false positive rate in selecting prepsychosis is at least about 60-70% in the very best of hands and may be as high as 90% in general practice. That’s right, folks, nine misidentified non patients for one accurately identified truly prepsychotic patient. Those are totally unacceptable odds.

What are the costs? McGorry does not recommend antipsychotic medications as a routine part of his prevention regimen. But experience teaches us that they will be overused despite having no proven efficacy and posing the risk of massive weight gain (and its consequent array of serious complications). The false positives will also suffer unnecessary stigma and worry and will undergo unnecessary and misdirected treatment. And surely there are many more productive ways to spend $400 million doing a better job of managing the mental health needs of those who have real and treatable psychiatric disorders.

Unfortunately, Mcgorry is a false prophet who’s visions are offered at least a few decades before their time. Australia, led astray by his impractical hopes, is about to embark on a vast and untried public health experiment that will almost surely cause more harm to its children than it prevents. Before embarking on this headlong and reckless rush, the following research steps need to be accomplished:

1)Developing a proven and reliable definition of “Psychosis Risk”

2)Learning how to use it in a way that reduces current outrageously high false positive rates to levels that are tolerable.

3)Demonstrating that the interventions chosen are indeed effective in preventing psychosis.

4)Determining the likely rate of antipsychotic use and how this influences the overall risk/benefit balance sheet of early intervention.

5)Studying the beneficial and harmful impacts of early diagnosis on stigma and self perception.

6)Comparing the marginal utility of a dollar spent trying to prevent an alleged future disorder vs a dollar spent treating an already clearly established one.

This is a research enterprise that will take many groups around the world many decades to complete. But it is an absolutely necessary precondition before spending $400 million on what is likely to be a failure. The Australian experiment will be flying blind on an airplane that is not at all ready to leave the ground. Doing prevention prematurely and poorly will give a good idea an unnecessary bad name.

McGorry’s intentions are clearly noble, but so were Don Quixote’s. The kindly knight’s delusional good intentions and misguided interventions wreaked havoc and confusion at every turn. Sad to say, Australia’s well intended impulse to protect its children will paradoxically put them at greater risk. Let’s applaud McGorry’s vision but not blindly follow him down an unknown path fraught with dangers.

Read article here:  http://www.psychologytoday.com/blog/dsm5-in-distress/201105/australias-reckless-experiment-in-early-intervention

« Return to news items


Share

The business of ADHD

Wednesday, May 25th, 2011

SFGate.com City Brights Blog
By Winston Chung, Child Psychiatrist
May 24, 2011

Psychiatrists convened in sunny Honolulu for the 164th Annual Meeting of the American Psychiatric Association (APA) last week, discussing, among other things, moving forward with plans to make the diagnostic criteria for ADHD less stringent: proposed changes include reducing the number of required symptoms from 6 to 4, for adults and teens, and increasing the age-of-onset criteria from 7 to 12.

Russell Barkley, Ph.D., and Joseph Biederman, M.D., have written about abandoning or generously broadening age-of-onset criteria, arguing that the current, precise age-of-onset criteria poses “unwarranted practical problems for the study of older adolescents and adults.” These two men are considered ADHD experts and contributed to the American Academy of Child and Adolescent Psychiatry (AACAP) Practice Parameters for ADHD, which serve as guidelines by which most child psychiatrists practice.

According to a story from the New York Times, Joseph Biederman did not tell university officials about more than a million dollars received from drugmakers from 2000 to 2007, and he promised Johnson & Johnson research results that would benefit the drug company. On the list of AACAP Conflicts of Interests for Practice Parameters not listed in the Practice Parameters, Russell Barkley receives or has received research support, acted as a consultant and/or served on a speaker’s bureau for Eli Lilly and Company and Shire Pharmaceuticals Group.

Shire Pharmaceuticals Group has a substantial focus on ADHD meds, and they have been pulling out all the stops to try and turn a profit in the face of competition from generic drugs.

Earlier this month, Reuter’s Health described how drugmakers, including Shire, have raised prices to make up for lack of new products and loss of patent protection.

“Prices were just shoved up every year to make more money and meet earnings, to be blunt,” Shire (SHP.L) Chief Executive Angus Russell said.

Shire’s CEO also indicated that the FDA is supporting their plan to study the use of their ADHD drug, Vyvanse, for use in depression and schizophrenia, hoping for billions of dollars in extra sales through expansion of potential indications. Amphetamines for schizophrenia? Hmmmm…..

Jim Edwards of BNET wrote about Shire increasing the price of one of their own ADHD drugs, Adderall XR, to encourage users to switch to their branded, cheaper and newer ADHD drug, Vyvanse, leading to increased sales.

Shire somehow sold more ADHD drugs during a recent, national shortage of ADHD medications – their sales of Adderall XR increased 21 percent in the first quarter of 2011 – a time when many of the patients in San Francisco’s public mental health system were unable to receive their regular ADHD medications.

BNET posted excerpts of separate lawsuits filed by Impax and Teva, manufacturers of generic forms of Adderall XR. They claim that Shire did not honor their contracts and hoarded product for themselves during this recent shortage. In the Wall Street Journal, the associate director of FDA’s drug shortages program reported that this national ADHD drug shortage mostly affected generic forms of ADHD meds. Coincidence?

Other ways of getting around stagnant drug development and generic competition include taking an old drug or active ingredient, and changing the delivery system or duration of action and presenting it as a new, patent-protected product. Here are a few examples that have been associated with Shire:

- Vyvanse: Also known as lisdexamfetamine, Vyvanse is a prodrug of dextroamphetamine. Dextroamphetamine has been used since 1937 to treat hyperactivity in children, so it is hardly new. Vyvanse was marketed as having lower abuse potential – specifically, preventing abuse from snorting, since the prodrug requires digestion to release the active form. In my clinical experience, most abuse of stimulants is due to people taking it without a prescription or shaping their symptoms to get a prescription, and a prodrug likely does little to curb college students from seeking stimulants to study for exams.

- Daytrana: The transdermal methylphenidate (methylphenidate is the active ingredient in Ritalin) patch is worn on the skin and was developed as a way of bypassing the digestive tract, and my experience prescribing this drug was met with equivocal reports from patients and families. I guess there is a reason I can’t remember anyone saying it worked – Shire gave up on the ADHD patch after 9 product recalls and a federal probe.

- Intuniv: An extended release form of guanfacine, Intuniv is touted as a new, non-stimulant treatment for ADHD. But child psychiatrists have been using guanfacine in ADHD for years, and this ‘extended-release’ form has a half-life of about 18 hours, while generic guanfacine has a half-life of about 17 hours – not a robust difference, in my opinion.

I liken these approaches to gimmicks utilized in the mass-produced, beer market: color changing labels to let you know if your beer is cold, wide-mouth beer cans, or vortex bottles. Do any of these ‘innovations’ really change the fact that you’re drinking cheap beer?

As the DSM-V looms closer to becoming a reality, I can’t help but think of words from the man who chaired the committee for the DSM-IV. Allen Frances, M.D., wrote in the in the LA Times:

As chairman of the task force that created the current Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which came out in 1994, I learned from painful experience how small changes in the definition of mental disorders can create huge, unintended consequences.

Our panel tried hard to be conservative and careful but inadvertently contributed to three false ‘epidemics’ – attention deficit disorder, autism and childhood bipolar disorder. Clearly, our net was cast too wide and captured many ‘patients’ who might have been far better off never entering the mental health system.

The DSM-IV was and the DSM-V will be published by the APA. The same APA that, in 2010, rejected internal recommendations – led by an APA past-president – to regulate or curtail individual psychiatrists’ relationships with the pharmaceutical industry.

Loosening the diagnostic criteria for ADHD, as proposed, will no doubt lead to more people being diagnosed and, inevitably, taking more ADHD drugs. I like to think that the APA and their doctors pushing for the changes are motivated by helping patients and not drug company profits.

After all, if anyone can identify and address unconscious conflicts or psychologically-defended, aggressive drives, it’s a psychiatrist, right?

Read article here:  http://www.sfgate.com/cgi-bin/blogs/wchung/detail?entry_id=89494

« Return to news items


Share

Grief is most definitely not a mental illness

Thursday, April 21st, 2011

The Daily News,  April 21, 2011

by Wendy Pratt

Those of us working at Nanaimo Hospice were shocked at this headline. The proposed revisions to the Diagnostic and Statistical Manual of Mental Disorders designating grief as a mental illness leaves us wondering if we, as humans, have lost our way. And although I am not a cynical person, one has to wonder who is behind this kind of move to “medicalize” grief — who would benefit most?

Let me be clear — grief is not a mental disorder. It is a natural reaction to a life transition that we must all face many times over a lifetime.

At hospice we know that accessing the right support and having someone to reassure you that you are not “going crazy” and that the emotions and physical symptoms you are experiencing are normal makes a huge difference.

What troubled me most was a quote by Dr. Allen Frances who is, in fact, against changes to the DSM, but who says, “the DSM already allows the diagnosis of major depression soon after a loss if the grief symptoms are severe — when the bereaved becomes incapacitated, suicidal, or psychotic.”

No one is going to disagree with psychoses — but incapacitation and suicidal ideation are not uncommon in the people hospice supports through their grief.

Some losses just seem too hard to move through, but we know that when people access our services, healing is possible.

I am reminded of a gentleman who was ready to end his life just days after his wife died. He came to hospice as the home care nurse’s urging. He was sure we could not help. After nine months of support he sent a card signed “from a reluctant client, you saved my life — thank you.”

A year and a half later he was planning his wedding to someone who had also suffered a loss. Together they honoured and celebrated the memories of their lost spouses at the same time as they were building a new life filled with hope and happiness.

As author Dr. Alan Wofelt once said, “grief is the price we pay for loving deeply.”   We concur.

http://www.canada.com/Grief+most+definitely+mental+illness/4654257/story.html

« Return to news items


Share

Psychiatrists Want To Label Grief a Mental Disorder

Monday, April 18th, 2011
The Montreal Gazette, April 18, 2011
By Sharon April 18, 2011

"This is a disaster," says Frances, a renowned U.S. psychiatrist who chaired the task force that wrote the current edition of the DSM

Human grief could soon be diagnosed as a mental disorder under a proposal critics fear could lead to mood-altering pills being pushed for “mourning.”

Psychiatrists charged with revising the official “bible” of mental illness are recommending changes that would make it easier for doctors to diagnose major depression in the newly bereaved.

Instead of having to wait months, the diagnosis could be made two weeks after the loss of a loved one.

The current edition of the Diagnostic and Statistical Manual of Mental Disorders – an influential tome used the world over – excludes people who have recently suffered a loss from being diagnosed with a major depressive disorder unless his or her symptoms persist beyond two months. It’s known as the “grief exclusion,” the theory being that “normal” grief shouldn’t be labelled a mental disorder.

But in what critics have called a potentially disastrous suggestion tucked among the proposed changes to the manual, “grief exclusion” would be eliminated from the DSM.

Proponents argue that major depression is major depression, that it makes little difference whether it comes on after the loss of a loved one, the loss of a job, the loss of a marriage or any other major life stressor. Eliminating “grief exclusion” would help people get treatment sooner than they otherwise would.

But critics fear that those experiencing completely expectable symptoms of grief would be labelled mentally “sick.” Dr. Allen Frances says the proposal would pathologize a normal human emotion and could bring on even wider prescribing of moodaltering pills.

“This is a disaster,” says Frances, a renowned U.S. psychiatrist who chaired the task force that wrote the current edition of the DSM, which is now undergoing its fifth revision. “Say you lose someone you love and two weeks later you feel sad, can’t sleep well, and have reduced interest, appetite, and energy. These five symptoms are completely typical of normal grieving, but DSM-5 would instead label you with a mental disorder.”

« Return to news items


Share

Shrinks on the couch as they ponder who is and is not crazy

Thursday, March 17th, 2011

Business Day – March 17, 2011

by Marika Sboros

At the heart of this matter is a nasty predilection some psychiatrists have for medicalising normality

Diagnosis is a slippery slope. It involves concepts that are virtually impossible to define precisely with bright lines at the boundaries

SOME psychiatrists — the ones who don’t believe they are godlike creatures — are in a bit of a tizz these days. They are worried about all the damage they might have unwittingly done by misdiagnosing mental illness.

Libyan leader Colonel Muammar Gaddafi could help to ease their furrowed brows.

Some background, before I explain that apparent non-sequitur: In a soul-searching analysis of his profession in Wired magazine recently, US psychiatrist Dr Allen Frances declares that mental disorders “can’t be defined”, and it’s “bull—-” to suggest otherwise.

Frances is lead editor of the DSM-IV, the fourth edition of the American Psychiatric Association’s Diagnostic and Statistical Manual. It’s a publication that has been described as “the bible” and “the imperial doctrine” of psychiatrists.

It’s what shrinks use, in their godlike wisdom, to decide whether or not you are mentally ill — and then to prescribe powerful, dangerous drugs, and other treatments that can turn you into a shadow of your former self.

In the gut-wrenching Wired article, Frances says: “We psychiatrists have made mistakes that had terrible consequences.”

In particular, he believes the manual has inadvertently facilitated the massive increase in recent years of diagnoses of autism, attention deficit disorders and bipolar depression — that used to be called manic depression, because of the manic swings in mood that characterise the condition.

He believes psychiatrists largely bear the responsibility for a massive increase in child bipolar diagnoses, and an epidemic of prescriptions for dangerous, antipsychotic drugs for very young children — below the age of five.

At the heart of this matter is a nasty predilection some psychiatrists have for medicalising normality, or as Wired writer Gary Greenberg says of the DSM, “to chalk up life’s difficulties to mental illness, and then treat them with psychiatric drugs”.

After all, it’s one thing to be thought of as having the blues after a protracted period of difficulty in your life. It’s quite another to be diagnosed as nuts. Mental illness is a serious diagnosis, aggravated by the burden of stigma that weighs down those deemed to have it. It wreaks havoc on lives, families, reputations and careers.

Yet diagnosis is a slippery slope. It involves concepts that “are virtually impossible to define precisely with bright lines at the boundaries”, says Frances.

He has accused colleagues “not just of bad science, but of bad faith, hubris, and blindness, of making diseases out of everyday suffering and, as a result, padding the bottom lines of drug companies”, as Greenberg so eloquently puts it.

Frances has joined forces with Dr Robert Spitzer, editor of the previous edition DSM-III, to prevent the current DSM-V from bulldozing its way down the same damaging path.

That’s a battle they look unlikely to win, given the power of the vested interests involved. And while this may all seem a little in-medical-house, it has implications for the many at the mercy of psychiatrists.

Frances fears the DSM will continue the “wholesale imperial medicalisation of normality”. It may create yet another bonanza for the pharmaceutical industry with a proposed, new “pre-psychotic disorder” — as if the manual doesn’t contain enough disorders from which pharmaceutical companies can make massive profits.

Of course, there’s nothing new about the idea that psychiatry is unscientific. The most famous proponent of that is US psychiatrist Dr Thomas Szaz, professor emeritus of psychiatry at the State University of New York Health Science Centre since 1990.

Szaz put his iconoclastic views forward in his books, The Myth of Mental Illness, published in 1960, and 10 years later in The Manufacture of Madness: A comparative study of the inquisition and the mental health movement.

These are damning critiques from a fine mind on psychiatry’s moral and scientific foundations — and mania for social control.

But what, you might ask, has this to do with Gaddafi?

Well, the Libyan leader is nothing if not a fascinating specimen, psychiatrically speaking, and an argument for the existence of mental illness. After all, if something looks like a duck, acts like a duck, walks like a duck, sounds like a duck, it’s a duck.

Gaddafi looks, acts, sounds and struts around like a madman. He provides a veritable smorgasbord of disorders guaranteed to titillate the mental tastebuds of orthodox psychiatrists, and have them reaching for their prescription pads in a flash.

Gaddafi, according to DSM specifications, could be diagnosed with borderline personality disorder — psychobabble psychiatrists have dreamt up to pigeonhole people who don’t or won’t do as others expect them to do.

He’s more likely to be diagnosed with into-the-abyss megalomania, paranoia, psychopathy, with a hint of schizophrenia.

Szaz might argue that Gaddafi’s madness is manufactured, a product of the toxic environment he created over the 42 years of his rule, wallowing in the absolute power that corrupts body and mind absolutely.

His bloated, puffy, sallow complexion suggests bad diet, and other unhealthy lifestyle habits that may contribute to the misfiring of neurons in his grey matter. Yet I doubt even the humane and holistic treatment methods Szaz advocates could bring Gaddafi back from the mad brink to anything resembling rational, normal, decent behaviour.

Marika Sboros is Health News editor.

http://www.businessday.co.za/articles/Content.aspx?id=137544

« Return to news items


Share

Psychiatric diagnostic manual editor reveals emperor has no clothes, “There is no definition of a mental disorder. It’s bull__.”

Monday, January 24th, 2011

Natural News — January 24, 2011

by Monica G. Young

"There is no definition of a mental disorder. It's bull___. I mean, you just can't define it." —Allen Frances, MD, lead editor for the Diagnostic Statistical Manual (DSM-IV).

“There is no definition of a mental disorder. It’s bull___. I mean, you just can’t define it,” states Allen Frances, MD, lead editor for the Diagnostic Statistical Manual (DSM-IV). As DSM-IV is the imperial doctrine used by psychiatrists in diagnosing mental disorders, prescribing powerful psychotropics to the masses, and commanding health care dollars, this is quite a confession. “We made mistakes that had terrible consequences,” Frances concedes.

Gary Greenberg who interviewed Frances and wrote an in-depth article for Wired Magazine, describes how Frances’ conscience has been hitting him in the gut. “Diagnoses of autism, attention-deficit hyperactivity disorder, and bipolar disorder skyrocketed, and Frances thinks his manual inadvertently facilitated these epidemics — and, in the bargain, fostered an increasing tendency to chalk up life’s difficulties to mental illness and then treat them with psychiatric drugs,” writes Greenberg.

DSM-IV led to a 40X increase in child bipolar diagnoses and an epidemic of dangerous antipsychotic prescriptions for children, even as young as 3.

Senior editor of DSM-III (the prior version), Robert Spitzer MD, had his own rude awakening. He is the one who spurred Frances to join him in battling against the creators of DSM-5 — the next edition in progress. Spitzer publicly censured the APA for mandating that psychiatrists involved in DSM-5 sign a written promise to never talk about what they were doing, except when necessary for their jobs. “The intent seemed to be not to let anyone know what…was going on,” says Spitzer.

Spitzer and Frances warn that including a proposed “pre-psychotic” disorder could lead to a new diagnosis explosion and drug company marketing onslaught. Frances says an emphasis on early intervention would encourage the “wholesale imperial medicalization of normality,” producing “a bonanza for the pharmaceutical industry” while imposing on patients the “high price [of] adverse effects, dollars, and stigma.”

There are many other dissenters in the field. Greenberg says “they are becoming increasingly restive, and some are beginning to agree with Frances that public pressure may be the only way to derail a train that he fears will ‘take psychiatry off a cliff.’”

Greenberg, himself a psychotherapist, points out that scientific certainty eludes psychiatry. He reports, “every fight over nomenclature threatens to undermine the legitimacy of the profession by revealing its dirty secret: that for all their confident pronouncements, psychiatrists can’t rigorously differentiate illness from everyday suffering.”

With 25% more mental disorders than DSM-III, DSM-IV has been a goldmine for drug companies. According to a 2006 study by Tufts University, more than half of the DSM-IV authors had financial links to the pharmaceutical industry.

Lacking medical research, the DSM-5 website is riddled with “deliberating”, “discussing”, and “heavy discussions” to describe how these professed experts attempt to decree new disorders. New proposals for DSM-5 include “Hoarding Disorder”, “Skin Picking Disorder” and worse, new labels for babies: “Temper Dysregulation Disorder” and “Feeding Disorder”. This would open the door to an infant drugging marketing campaign!

Like the tale of the pompous emperor who pretends his clothes are so magnificent they can only be seen by wise people, the psychiatric and drug industries peddle their fabricated labels and drug remedies to the world. And like the little boy who shouts the obvious “the emperor has no clothes”, it’s up to public pressure to stop this.

For more information see  Psychiatric Disorders: The Facts Behind the Billion Dollar Marketing Campaign, by CCHR International http://www.cchrint.org/psychiatric-disorders/

« Return to news items


Share

What’s A Mental Disorder? Even Experts Can’t Agree

Thursday, December 30th, 2010
The definitions for some mental illnesses may change.

Mark Strozier/iStockphoto.com

NPR— December 29, 2010

by Alix Spiegel

The American Psychiatric Association’s Diagnostic and Statistical Manual, or DSM, updated roughly every 15 years, has detailed descriptions of all the mental disorders officially recognized by psychiatry. It’s used by psychiatrists, insurance companies, drug researchers, the courts and even schools.

But it’s not without controversy: The proposed changes suggested this year have sparked a kind of civil war within psychiatry.

In a small condo on the beach in San Diego lives Allen Frances, who blames himself for what he calls the “Epidemic of Asperger’s.” Frances edited the last edition of the DSM, and he’s also the new DSM’s most prominent critic. Frances is the one who put the word Asperger’s in the DSM in the first place, thereby making it an official mental disorder.

In the editions before Frances was editor, there was an entry for autism, but it was defined by severe symptoms. Frances says doctors felt the diagnosis for autism didn’t cover a more mild disorder they were actually encountering.

“Pediatricians and child psychiatrists would see kids who could talk but who had social discomfort — severe social discomfort — and awkwardness and a very restricted and impairing level of interests and activities, and they wanted a diagnosis for this,” Frances says.

A study was done to figure out how common Asperger’s was, and the results were clear: It was vanishingly rare. Then Frances put it in the DSM, and the number of kids diagnosed with the disorder exploded. Frances remembers sitting in his condo reading articles about this new epidemic of Asperger’s that was sweeping the nation.

“At that point I did an ‘oops,’ ” he says. “This is a complete misunderstanding. It was distressing. Quite distressing.”

Ellen Webber/NPR

Surprising Incentives

It’s not that Frances doesn’t think that Asperger’s exists and is a real problem for some people; he does. But he also believes the diagnosis is now radically overused in a way that he and his colleagues never intended. And why, in his view, did Asperger’s explode? Primarily, Frances says, because schools created a strange unintentional incentive.

“In order to get specialized services, often one-to-one education, a child must have a diagnosis of Asperger’s or some other autistic disorder,” he says.

“And so kids who previously might have been considered on the boundary, eccentric, socially shy, but bright and doing well in school would mainstream [into] regular classes,” Frances says. “Now if they get the diagnosis of Asperger’s disorder, [they] get into a special program where they may get $50,000 a year worth of educational services.”

Disturbing Consequences

Frances worried this might cause a misallocation of school resources. And Frances points to another change he made — which, for him, has had even more disturbing consequences. Essentially, Frances and his colleagues made it much easier to get a diagnosis of bipolar disorder. And he says that created this incredible opportunity for drug companies.

“Drug companies got indications for treating bipolar disorder,” Frances says. “Not just with mood stabilizers, but also with the newer antipsychotic drugs. And they began very intensive ubiquitous advertising campaigns. So the rates of bipolar disorder doubled. And lots of people got way too much antipsychotic and mood stabilizing medicines. And these aren’t safe drugs.”

And for Frances, the lesson of these experiences is clear. Once you put a new diagnosis in the DSM, there is no controlling what will happen to it. So there’s only one thing to do:

“Anticipate the worst. If something can be misused, it will be misused,” Frances says. “If diagnosis can lead to overdiagnosis and overtreatment, that will happen. So you need to be very, very cautious in making changes that may open the door for a flood of fad diagnoses.”

As far as Frances is concerned, the new DSM is proposing too many diagnoses that are written in too broad a way, meaning that ultimately a huge number of new people will be categorized as mentally ill.

Read the rest of the article here: http://www.npr.org/2010/12/29/132407384/whats-a-mental-disorder-even-experts-cant-agree

To read statements from other psychiatrists/psychologists on the lack of science to support mental disorders as legitimate “illnesses” click here:
http://www.cchrint.org/psychiatric-disorders/psychiatrists-on-lack-of-any-medical-or-scientific-tests/

« Return to news items


Share

DSM: The Book of Woe—Inside the Battle to Define Mental Illness

Monday, December 27th, 2010

Wired—December 27, 2010

by Gary Greenberg

Every so often Al Frances says something that seems to surprise even him. Just now, for instance, in the predawn darkness of his comfortable, rambling home in Carmel, California, he has broken off his exercise routine to declare that “there is no definition of a mental disorder. It’s bullshit. I mean, you just can’t define it.” Then an odd, reflective look crosses his face, as if he’s taking in the strangeness of this scene: Allen Frances, lead editor of the fourth edition of the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders (universally known as the DSM-IV), the guy who wrote the book on mental illness, confessing that “these concepts are virtually impossible to define precisely with bright lines at the boundaries.” For the first time in two days, the conversation comes to an awkward halt.

But he recovers quickly, and back in the living room he finishes explaining why he came out of a seemingly contented retirement to launch a bitter and protracted battle with the people, some of them friends, who are creating the next edition of the DSM. And to criticize them not just once, and not in professional mumbo jumbo that would keep the fight inside the professional family, but repeatedly and in plain English, in newspapers and magazines and blogs. And to accuse his colleagues not just of bad science but of bad faith, hubris, and blindness, of making diseases out of everyday suffering and, as a result, padding the bottom lines of drug companies. These aren’t new accusations to level at psychiatry, but Frances used to be their target, not their source. He’s hurling grenades into the bunker where he spent his entire career.

One influential advocate for diagnosing bipolar disorder in kids failed to disclose money he received from the makers of the bipolar drug Risperdal.

As a practicing psychotherapist myself, I can attest that this is a startling turn. But when Frances tries to explain it, he resists the kinds of reasons that mental health professionals usually give each other, the ones about character traits or personality quirks formed in childhood. He says he doesn’t want to give ammunition to his enemies, who have already shown their willingness to “shoot the messenger.” It’s not an unfounded concern. In its first official response to Frances, the APA diagnosed him with “pride of authorship” and pointed out that his royalty payments would end once the new edition was published—a fact that “should be considered when evaluating his critique and its timing.”

Frances, who claims he doesn’t care about the royalties (which amount, he says, to just 10 grand a year), also claims not to mind if the APA cites his faults. He just wishes they’d go after the right ones—the serious errors in the DSM-IV. “We made mistakes that had terrible consequences,” he says. Diagnoses of autism, attention-deficit hyperactivity disorder, and bipolar disorder skyrocketed, and Frances thinks his manual inadvertently facilitated these epidemics—and, in the bargain, fostered an increasing tendency to chalk up life’s difficulties to mental illness and then treat them with psychiatric drugs.

The insurgency against the DSM-5 (the APA has decided to shed the Roman numerals) has now spread far beyond just Allen Frances. Psychiatrists at the top of their specialties, clinicians at prominent hospitals, and even some contributors to the new edition have expressed deep reservations about it. Dissidents complain that the revision process is in disarray and that the preliminary results, made public for the first time in February 2010, are filled with potential clinical and public relations nightmares. Although most of the dissenters are squeamish about making their concerns public—especially because of a surprisingly restrictive nondisclosure agreement that all insiders were required to sign—they are becoming increasingly restive, and some are beginning to agree with Frances that public pressure may be the only way to derail a train that he fears will “take psychiatry off a cliff.”

At stake in the fight between Frances and the APA is more than professional turf, more than careers and reputations, more than the $6.5 million in sales that the DSM averages each year. The book is the basis of psychiatrists’ authority to pronounce upon our mental health, to command health care dollars from insurance companies for treatment and from government agencies for research. It is as important to psychiatrists as the Constitution is to the US government or the Bible is to Christians. Outside the profession, too, the DSM rules, serving as the authoritative text for psychologists, social workers, and other mental health workers; it is invoked by lawyers in arguing over the culpability of criminal defendants and by parents seeking school services for their children. If, as Frances warns, the new volume is an “absolute disaster,” it could cause a seismic shift in the way mental health care is practiced in this country. It could cause the APA to lose its franchise on our psychic suffering, the naming rights to our pain.

This is hardly the first time that defining mental illness has led to rancor within the profession. It happened in 1993, when feminists denounced Frances for considering the inclusion of “late luteal phase dysphoric disorder” (formerly known as premenstrual syndrome) as a possible diagnosis for DSM-IV. It happened in 1980, when psychoanalysts objected to the removal of the word neurosis—their bread and butter—from the DSM-III. It happened in 1973, when gay psychiatrists, after years of loud protest, finally forced a reluctant APA to acknowledge that homosexuality was not and never had been an illness. Indeed, it’s been happening since at least 1922, when two prominent psychiatrists warned that a planned change to the nomenclature would be tantamount to declaring that “the whole world is, or has been, insane.”

Some of this disputatiousness is the hazard of any professional specialty. But when psychiatrists say, as they have during each of these fights, that the success or failure of their efforts could sink the whole profession, they aren’t just scoring rhetorical points. The authority of any doctor depends on their ability to name a patient’s suffering. For patients to accept a diagnosis, they must believe that doctors know—in the same way that physicists know about gravity or biologists about mitosis—that their disease exists and that they have it. But this kind of certainty has eluded psychiatry, and every fight over nomenclature threatens to undermine the legitimacy of the profession by revealing its dirty secret: that for all their confident pronouncements, psychiatrists can’t rigorously differentiate illness from everyday suffering. This is why, as one psychiatrist wrote after the APA voted homosexuality out of the DSM, “there is a terrible sense of shame among psychiatrists, always wanting to show that our diagnoses are as good as the scientific ones used in real medicine.”

If bad tests are sanctioned in the DSM, insurance companies might use them to cut off coverage for patients deemed not sick enough. It could be a disaster.

Since 1980, when the DSM-III was published, psychiatrists have tried to solve this problem by using what is called descriptive diagnosis: a checklist approach, whereby illnesses are defined wholly by the symptoms patients present. The main virtue of descriptive psychiatry is that it doesn’t rely on unprovable notions about the nature and causes of mental illness, as the Freudian theories behind all those “neuroses” had done. Two doctors who observe a patient carefully and consult the DSM’s criteria lists usually won’t disagree on the diagnosis—something that was embarrassingly common before 1980. But descriptive psychiatry also has a major problem: Its diagnoses are nothing more than groupings of symptoms. If, during a two-week period, you have five of the nine symptoms of depression listed in the DSM, then you have “major depression,” no matter your circumstances or your own perception of your troubles. “No one should be proud that we have a descriptive system,” Frances tells me. “The fact that we do only reveals our limitations.” Instead of curing the profession’s own malady, descriptive psychiatry has just covered it up.

Read the rest of the article here:

http://www.wired.com/magazine/2010/12/ff_dsmv/all/1

« Return to news items


Share